Body 0 4 0 4 B-clinical_variable
weight 5 11 5 11 I-clinical_variable
greater 12 19 12 19 O
than 20 24 20 24 O
33.4 25 29 25 29 B-lower_bound
kg 30 32 30 32 I-lower_bound

Current 0 7 33 40 O
or 8 10 41 43 O
past 11 15 44 48 O
history 16 23 49 56 O
of 24 26 57 59 O
any 27 30 60 63 O
significant 31 42 64 75 O
psychiatric 43 54 76 87 B-chronic_disease
disorder 55 63 88 96 I-chronic_disease
including 64 73 97 106 O
, 73 74 106 107 O
but 75 78 108 111 O
not 79 82 112 115 O
limited 83 90 116 123 O
to 91 93 124 126 O
, 93 94 126 127 O
depression 95 105 128 138 B-chronic_disease
( 106 107 139 140 O
treatment 107 116 140 149 B-treatment
with 117 121 150 154 I-treatment
antidepressants 122 137 155 170 I-treatment
) 137 138 170 171 O
, 138 139 171 172 O
bipolar 140 147 173 180 B-chronic_disease
disorder 148 156 181 189 I-chronic_disease
, 156 157 189 190 O
or 158 160 191 193 O
schizophrenia 161 174 194 207 B-chronic_disease

Currently 0 9 208 217 O
meet 10 14 218 222 O
Diagnostic 15 25 223 233 O
and 26 29 234 237 O
Statistical 30 41 238 249 O
Manual 42 48 250 256 O
of 49 51 257 259 O
Mental 52 58 260 266 O
Disorders 59 68 267 276 O
- 69 70 277 278 O
Fifth 71 76 279 284 O
Edition 77 84 285 292 O
( 85 86 293 294 O
DSM-5 86 91 294 299 O
) 91 92 299 300 O
criteria 93 101 301 309 O
for 102 105 310 313 O
substance 106 115 314 323 O
use 116 119 324 327 O
disorder 120 128 328 336 O
, 128 129 336 337 O
or 130 132 338 340 O
history 133 140 341 348 O
thereof 141 148 349 356 O
, 148 149 356 357 O
within 150 156 358 364 O
12 157 159 365 367 B-upper_bound
months 160 166 368 374 I-upper_bound
before 167 173 375 381 I-upper_bound
dosing 174 180 382 388 O

Diagnosis 0 9 389 398 O
of 10 12 399 401 O
ADHD 13 17 402 406 B-chronic_disease

Estimated 0 9 407 416 B-clinical_variable
creatinine 10 20 417 427 I-clinical_variable
clearance 21 30 428 437 I-clinical_variable
of 31 33 438 440 O
at 34 36 441 443 O
least 37 42 444 449 O
60 43 45 450 452 B-lower_bound
mL 46 48 453 455 I-lower_bound
/ 48 49 455 456 I-lower_bound
min 49 52 456 459 I-lower_bound
( 53 54 460 461 O
using 54 59 461 466 O
the 60 63 467 470 O
Cockcroft 64 73 471 480 O
- 73 74 480 481 O
Gault 74 79 481 486 O
equation 80 88 487 495 O
) 88 89 495 496 O
at 90 92 497 499 O
screening 93 102 500 509 O
only 103 107 510 514 O

Female 0 6 515 521 B-gender
patients 7 15 522 530 I-gender

History 0 7 531 538 O
of 8 10 539 541 O
a 11 12 542 543 O
primary 13 20 544 551 B-chronic_disease
sleep 21 26 552 557 I-chronic_disease
disorder 27 35 558 566 I-chronic_disease
other 36 41 567 572 O
than 42 46 573 577 O
RLS 47 50 578 581 B-chronic_disease
that 51 55 582 586 O
may 56 59 587 590 O
significantly 60 73 591 604 O
affect 74 80 605 611 O
the 81 84 612 615 O
symptoms 85 93 616 624 O
of 94 96 625 627 O
RLS 97 100 628 631 O

History 0 7 632 639 O
of 8 10 640 642 O
allergy 11 18 643 650 O
, 18 19 650 651 O
hypersensitivity 20 36 652 668 O
, 36 37 668 669 O
or 38 40 670 672 O
intolerance 41 52 673 684 O
to 53 55 685 687 O
HORIZANT 56 64 688 696 B-allergy_name
or 65 67 697 699 O
any 68 71 700 703 O
other 72 77 704 709 O
gabapentin 78 88 710 720 B-allergy_name
products 89 97 721 729 I-allergy_name
( 98 99 730 731 O
e.g. 99 103 731 735 O
, 103 104 735 736 O
Neurontin 105 114 737 746 B-allergy_name
® 114 115 746 747 I-allergy_name
, 115 116 747 748 O
Gralise 117 124 749 756 B-allergy_name
® 124 125 756 757 I-allergy_name
) 125 126 757 758 O

History 0 7 759 766 O
of 8 10 767 769 O
suicidal 11 19 770 778 B-chronic_disease
behavior 20 28 779 787 I-chronic_disease
or 29 31 788 790 I-chronic_disease
suicidal 32 40 791 799 I-chronic_disease
ideation 41 49 800 808 I-chronic_disease
as 50 52 809 811 O
indicated 53 62 812 821 O
by 63 65 822 824 O
the 66 69 825 828 O
C 70 71 829 830 B-clinical_variable
- 71 72 830 831 I-clinical_variable
SSRS 72 76 831 835 I-clinical_variable
, 76 77 835 836 O
administered 78 90 837 849 O
at 91 93 850 852 O
screening 94 103 853 862 O
, 103 104 862 863 O
and 105 108 864 867 O
as 109 111 868 870 O
per 112 115 871 874 O
investigator 116 128 875 887 O
's 128 130 887 889 O
judgment 131 139 890 898 O

Male 0 4 899 903 B-gender

Male 0 4 904 908 B-gender
patients 5 13 909 917 I-gender

Medical 0 7 918 925 B-chronic_disease
condition 8 17 926 935 I-chronic_disease
or 18 20 936 938 O
disorder 21 29 939 947 O
that 30 34 948 952 O
would 35 40 953 958 O
interfere 41 50 959 968 O
with 51 55 969 973 O
the 56 59 974 977 O
action 60 66 978 984 O
, 66 67 984 985 O
absorption 68 78 986 996 O
, 78 79 996 997 O
distribution 80 92 998 1010 O
, 92 93 1010 1011 O
metabolism 94 104 1012 1022 O
, 104 105 1022 1023 O
or 106 108 1024 1026 O
excretion 109 118 1027 1036 O
of 119 121 1037 1039 O
gabapentin 122 132 1040 1050 B-treatment
enacarbil 133 142 1051 1060 I-treatment
, 142 143 1060 1061 O
or 144 146 1062 1064 O
, 146 147 1064 1065 O
in 148 150 1066 1068 O
the 151 154 1069 1072 O
Principal 155 164 1073 1082 O
Investigator 165 177 1083 1095 O
's 177 179 1095 1097 O
judgment 180 188 1098 1106 O
is 189 191 1107 1109 O
considered 192 202 1110 1120 O
to 203 205 1121 1123 O
be 206 208 1124 1126 O
clinically 209 219 1127 1137 O
significant 220 231 1138 1149 O
and 232 235 1150 1153 O
may 236 239 1154 1157 O
pose 240 244 1158 1162 O
a 245 246 1163 1164 O
safety 247 253 1165 1171 O
concern 254 261 1172 1179 O
, 261 262 1179 1180 O
or 263 265 1181 1183 O
, 265 266 1183 1184 O
could 267 272 1185 1190 O
interfere 273 282 1191 1200 O
with 283 287 1201 1205 O
the 288 291 1206 1209 O
accurate 292 300 1210 1218 O
assessment 301 311 1219 1229 O
of 312 314 1230 1232 O
safety 315 321 1233 1239 O
or 322 324 1240 1242 O
efficacy 325 333 1243 1251 O
, 333 334 1251 1252 O
or 335 337 1253 1255 O
could 338 343 1256 1261 O
potentially 344 355 1262 1273 O
affect 356 362 1274 1280 O
a 363 364 1281 1282 O
patient 365 372 1283 1290 O
's 372 374 1290 1292 O
safety 375 381 1293 1299 O
or 382 384 1300 1302 O
study 385 390 1303 1308 O
outcome 391 398 1309 1316 O

Negative 0 8 1317 1325 B-pregnancy
pregnancy 9 18 1326 1335 I-pregnancy
test 19 23 1336 1340 O
for 24 27 1341 1344 O
all 28 31 1345 1348 O
females 32 39 1349 1356 B-gender
at 40 42 1357 1359 O
screening 43 52 1360 1369 O
and 53 56 1370 1373 O
baseline 57 65 1374 1382 O

Participated 0 12 1383 1395 O
in 13 15 1396 1398 O
an 16 18 1399 1401 O
investigational 19 34 1402 1417 B-treatment
drug 35 39 1418 1422 I-treatment
trial 40 45 1423 1428 I-treatment
within 46 52 1429 1435 O
the 53 56 1436 1439 O
4 57 58 1440 1441 B-upper_bound
weeks 59 64 1442 1447 I-upper_bound
before 65 71 1448 1454 I-upper_bound
dosing 72 78 1455 1461 O
or 79 81 1462 1464 O
plans 82 87 1465 1470 O
to 88 90 1471 1473 O
participate 91 102 1474 1485 O
in 103 105 1486 1488 O
another 106 113 1489 1496 B-treatment
study 114 119 1497 1502 I-treatment
at 120 122 1503 1505 O
any 123 126 1506 1509 O
time 127 131 1510 1514 O
during 132 138 1515 1521 O
this 139 143 1522 1526 O
study 144 149 1527 1532 O

Patients 0 8 1533 1541 O
with 9 13 1542 1546 O
a 14 15 1547 1548 O
history 16 23 1549 1556 O
of 24 26 1557 1559 O
epilepsy 27 35 1560 1568 B-chronic_disease
, 35 36 1568 1569 O
subjects 37 45 1570 1578 O
currently 46 55 1579 1588 O
prescribed 56 66 1589 1599 B-treatment
treatments 67 77 1600 1610 I-treatment
for 78 81 1611 1614 O
epilepsy 82 90 1615 1623 O
, 90 91 1623 1624 O
or 92 94 1625 1627 O
subjects 95 103 1628 1636 O
with 104 108 1637 1641 O
a 109 110 1642 1643 O
history 111 118 1644 1651 O
of 119 121 1652 1654 O
seizure 122 129 1655 1662 B-chronic_disease
in 130 132 1663 1665 O
the 133 136 1666 1669 O
last 137 141 1670 1674 B-upper_bound
5 142 143 1675 1676 I-upper_bound
years 144 149 1677 1682 I-upper_bound

Positive 0 8 1683 1691 O
test 9 13 1692 1696 O
for 14 17 1697 1700 O
hepatitis 18 27 1701 1710 B-chronic_disease
B 28 29 1711 1712 I-chronic_disease
surface 30 37 1713 1720 O
antigen 38 45 1721 1728 O
( 46 47 1729 1730 O
HBsAg 47 52 1730 1735 O
) 52 53 1735 1736 O
, 53 54 1736 1737 O
hepatitis 55 64 1738 1747 B-chronic_disease
C 65 66 1748 1749 I-chronic_disease
virus 67 72 1750 1755 I-chronic_disease
( 73 74 1756 1757 I-chronic_disease
HCV 74 77 1757 1760 I-chronic_disease
) 77 78 1760 1761 I-chronic_disease
antibody 79 87 1762 1770 O
, 87 88 1770 1771 O
human 89 94 1772 1777 B-chronic_disease
immunodeficiency 95 111 1778 1794 I-chronic_disease
virus 112 117 1795 1800 I-chronic_disease
( 118 119 1801 1802 I-chronic_disease
HIV 119 122 1802 1805 I-chronic_disease
) 122 123 1805 1806 I-chronic_disease
antibody 124 132 1807 1815 O
at 133 135 1816 1818 O
screening 136 145 1819 1828 O

RLS 0 3 1829 1832 B-chronic_disease
symptoms 4 12 1833 1841 O
for 13 16 1842 1845 O
at 17 19 1846 1848 O
least 20 25 1849 1854 O
4 26 27 1855 1856 B-lower_bound
of 28 30 1857 1859 O
7 31 32 1860 1861 B-upper_bound
consecutive 33 44 1862 1873 O
evenings 45 53 1874 1882 O
/ 53 54 1882 1883 O
nights 54 60 1883 1889 O
during 61 67 1890 1896 O
the 68 71 1897 1900 O
screening 72 81 1901 1910 O
period 82 88 1911 1917 O

Received 0 8 1918 1926 O
an 9 11 1927 1929 O
investigational 12 27 1930 1945 B-treatment
product 28 35 1946 1953 I-treatment
within 36 42 1954 1960 O
6 43 44 1961 1962 B-upper_bound
months 45 51 1963 1969 I-upper_bound
prior 52 57 1970 1975 I-upper_bound
to 58 60 1976 1978 O
dosing 61 67 1979 1985 O

Serum 0 5 1986 1991 B-clinical_variable
ferritin 6 14 1992 2000 I-clinical_variable
level 15 20 2001 2006 I-clinical_variable
< 21 22 2007 2008 O
20 23 25 2009 2011 B-upper_bound
ng 26 28 2012 2014 I-upper_bound
/ 28 29 2014 2015 I-upper_bound
mL 29 31 2015 2017 I-upper_bound
at 32 34 2018 2020 O
screening 35 44 2021 2030 O

Sexually 0 8 2031 2039 O
active 9 15 2040 2046 O
patients 16 24 2047 2055 O
must 25 29 2056 2060 O
agree 30 35 2061 2066 B-contraception_consent
to 36 38 2067 2069 I-contraception_consent
use 39 42 2070 2073 I-contraception_consent
2 43 44 2074 2075 I-contraception_consent
medically 45 54 2076 2085 I-contraception_consent
accepted 55 63 2086 2094 I-contraception_consent
methods 64 71 2095 2102 I-contraception_consent
of 72 74 2103 2105 I-contraception_consent
contraception 75 88 2106 2119 I-contraception_consent
, 88 89 2119 2120 O
1 90 91 2121 2122 O
of 92 94 2123 2125 O
which 95 100 2126 2131 O
is 101 103 2132 2134 O
a 104 105 2135 2136 O
highly 106 112 2137 2143 O
effective 113 122 2144 2153 O
method 123 129 2154 2160 O
( 130 131 2161 2162 O
e.g. 131 135 2162 2166 O
, 135 136 2166 2167 O
hormonal 137 145 2168 2176 B-contraception_consent
or 146 148 2177 2179 O
intrauterine 149 161 2180 2192 B-contraception_consent
device 162 168 2193 2199 I-contraception_consent
[ 169 170 2200 2201 I-contraception_consent
IUD 170 173 2201 2204 I-contraception_consent
] 173 174 2204 2205 I-contraception_consent
) 174 175 2205 2206 O
[ 176 177 2207 2208 O
the 177 180 2208 2211 O
second 181 187 2212 2218 O
may 188 191 2219 2222 O
be 192 194 2223 2225 O
a 195 196 2226 2227 O
barrier 197 204 2228 2235 B-contraception_consent
method 205 211 2236 2242 I-contraception_consent
( 212 213 2243 2244 O
e.g. 213 217 2244 2248 O
, 217 218 2248 2249 O
male 219 223 2250 2254 B-contraception_consent
condom 224 230 2255 2261 I-contraception_consent
, 230 231 2261 2262 O
female 232 238 2263 2269 B-contraception_consent
condom 239 245 2270 2276 I-contraception_consent
, 245 246 2276 2277 O
diaphragm 247 256 2278 2287 B-contraception_consent
or 257 259 2288 2290 O
cervical 260 268 2291 2299 B-contraception_consent
cap 269 272 2300 2303 I-contraception_consent
) 272 273 2303 2304 O
] 273 274 2304 2305 O
, 274 275 2305 2306 O
during 276 282 2307 2313 O
the 283 286 2314 2317 O
course 287 293 2318 2324 O
of 294 296 2325 2327 O
the 297 300 2328 2331 O
study 301 306 2332 2337 O
treatment 307 316 2338 2347 B-treatment
and 317 320 2348 2351 O
for 321 324 2352 2355 O
4 325 326 2356 2357 B-upper_bound
weeks 327 332 2358 2363 I-upper_bound
after 333 338 2364 2369 I-upper_bound
the 339 342 2370 2373 O
last 343 347 2374 2378 O
dose 348 352 2379 2383 O
of 353 355 2384 2386 O
study 356 361 2387 2392 O
treatment 362 371 2393 2402 O

Suffering 0 9 2403 2412 O
from 10 14 2413 2417 O
an 15 17 2418 2420 O
isolated 18 26 2421 2429 O
periodic 27 35 2430 2438 B-chronic_disease
limb 36 40 2439 2443 I-chronic_disease
movement 41 49 2444 2452 I-chronic_disease
disorder 50 58 2453 2461 I-chronic_disease
without 59 66 2462 2469 O
RLS 67 70 2470 2473 B-chronic_disease

Total 0 5 2474 2479 B-clinical_variable
RLS 6 9 2480 2483 I-clinical_variable
severity 10 18 2484 2492 I-clinical_variable
score 19 24 2493 2498 I-clinical_variable
of 25 27 2499 2501 O
15 28 30 2502 2504 B-lower_bound
or 31 33 2505 2507 O
greater 34 41 2508 2515 O
on 42 44 2516 2518 O
the 45 48 2519 2522 O
IRLS 49 53 2523 2527 B-clinical_variable
rating 54 60 2528 2534 I-clinical_variable
scale 61 66 2535 2540 I-clinical_variable
at 67 69 2541 2543 O
Visit 70 75 2544 2549 O
1 76 77 2550 2551 O
( 78 79 2552 2553 O
screening 79 88 2553 2562 O
) 88 89 2562 2563 O
and 90 93 2564 2567 O
at 94 96 2568 2570 O
Visit 97 102 2571 2576 O
2 103 104 2577 2578 O
( 105 106 2579 2580 O
baseline 106 114 2580 2588 O
) 114 115 2588 2589 O

Uncontrolled 0 12 2590 2602 B-chronic_disease
hypertension 13 25 2603 2615 I-chronic_disease
defined 26 33 2616 2623 O
as 34 36 2624 2626 O
blood 37 42 2627 2632 B-clinical_variable
pressure 43 51 2633 2641 I-clinical_variable
( 52 53 2642 2643 I-clinical_variable
BP 53 55 2643 2645 I-clinical_variable
) 55 56 2645 2646 I-clinical_variable
≥ 57 58 2647 2648 O
95 59 61 2649 2651 B-lower_bound
percentile 62 72 2652 2662 I-lower_bound
adjusted 73 81 2663 2671 O
for 82 85 2672 2675 O
age 86 89 2676 2679 B-age
, 89 90 2679 2680 O
height 91 97 2681 2687 O
, 97 98 2687 2688 O
and 99 102 2689 2692 O
sex 103 106 2693 2696 O
, 106 107 2696 2697 O
according 108 117 2698 2707 O
to 118 120 2708 2710 O
the 121 124 2711 2714 O
tables 125 131 2715 2721 O
published 132 141 2722 2731 O
by 142 144 2732 2734 O
the 145 148 2735 2738 O
US 149 151 2739 2741 O
Department 152 162 2742 2752 O
of 163 165 2753 2755 O
Health 166 172 2756 2762 O
and 173 176 2763 2766 O
Human 177 182 2767 2772 O
Services 183 191 2773 2781 O
2005 192 196 2782 2786 O
, 196 197 2786 2787 O
at 198 200 2788 2790 O
screening 201 210 2791 2800 O
and 211 214 2801 2804 O
before 215 221 2805 2811 O
dosing 222 228 2812 2818 O

a 0 1 2819 2820 O
healthy 2 9 2821 2828 O
weight 10 16 2829 2835 O
using 17 22 2836 2841 O
age 23 26 2842 2845 B-age
- 26 27 2845 2846 O
based 27 32 2846 2851 O
body 33 37 2852 2856 B-bmi
mass 38 42 2857 2861 I-bmi
index 43 48 2862 2867 I-bmi
( 49 50 2868 2869 I-bmi
BMI 50 53 2869 2872 I-bmi
) 53 54 2872 2873 I-bmi
range 55 60 2874 2879 O
5th-95th 61 69 2880 2888 B-lower_bound
percentile 70 80 2889 2899 I-upper_bound
at 81 83 2900 2902 O
screening 84 93 2903 2912 O
and 94 97 2913 2916 O
baseline 98 106 2917 2925 O

aged 0 4 2926 2930 B-age
13 5 7 2931 2933 B-lower_bound
to 8 10 2934 2936 O
17 11 13 2937 2939 B-upper_bound
years 14 19 2940 2945 I-upper_bound

diagnosed 0 9 2946 2955 O
with 10 14 2956 2960 O
RLS 15 18 2961 2964 B-chronic_disease
based 19 24 2965 2970 O
on 25 27 2971 2973 O
the 28 31 2974 2977 O
IRLSSG 32 38 2978 2984 O
consensus 39 48 2985 2994 O
criteria 49 57 2995 3003 O
( 58 59 3004 3005 O
Allen 59 64 3005 3010 O
RP 65 67 3011 3013 O
2014 68 72 3014 3018 O
) 72 73 3018 3019 O

female 0 6 3020 3026 B-gender
adolescent 7 17 3027 3037 O
patients 18 26 3038 3046 O

patients 0 8 3047 3055 O
using 9 14 3056 3061 B-contraception_consent
hormonal 15 23 3062 3070 I-contraception_consent
contraceptives 24 38 3071 3085 I-contraception_consent
as 39 41 3086 3088 O
one 42 45 3089 3092 O
of 46 48 3093 3095 O
the 49 52 3096 3099 O
methods 53 60 3100 3107 O
, 60 61 3107 3108 O
the 62 65 3109 3112 O
contraceptive 66 79 3113 3126 O
should 80 86 3127 3133 O
be 87 89 3134 3136 O
stabilized 90 100 3137 3147 O
for 101 104 3148 3151 O
at 105 107 3152 3154 O
least 108 113 3155 3160 O
3 114 115 3161 3162 B-lower_bound
months 116 122 3163 3169 I-lower_bound
prior 123 128 3170 3175 I-lower_bound
to 129 131 3176 3178 O
screening 132 141 3179 3188 O

